/> – Understand the inspection objectives, such as validating quality systems, verifying manufacturing processes, and confirming the accuracy of submitted data.

4.1.2 Assemble the Inspection Team
– Form a dedicated Pre-Approval Inspection team with representatives from:
– Regulatory Affairs.
– Quality Assurance.
– Production.
– R&D (Research and Development).
– Assign roles and responsibilities, such as:
– Escorting the FDA inspector.
– Document retrieval.
– Technical explanations.

4.2 Facility and Documentation Readiness
4.2.1 Facility Preparation
– Conduct a walkthrough of the facility to identify and correct any compliance gaps.
– Ensure cleanliness and order in all areas, including:
– Manufacturing floors.
– Storage areas.
– Laboratory and testing facilities.
– Label equipment, materials, and products clearly.

4.2.2 Documentation Preparation
– Ensure all documents are complete, up-to-date, and readily accessible, including:
– Quality manuals and Standard Operating Procedures (SOPs).
– Device Master Records (DMRs) and Device History Records (DHRs).
– Validation and verification reports.
– Risk management files.
– Verify document control processes are compliant with FDA requirements.

4.3 Conducting Mock Inspections
4.3.1 Internal Mock Inspection
– Perform an internal mock inspection simulating FDA protocols:
– Evaluate employee readiness to respond to inspector questions.
– Test the speed and accuracy of document retrieval.
– Identify and address potential non-conformities.
– Document findings in the Mock Inspection Log.

4.3.2 Third-Party Audit
– Engage a third-party consultant for an external audit to assess readiness.
– Use findings to refine processes and address gaps.

4.4 Employee Training
4.4.1 Training Programs
– Conduct training sessions on FDA inspection protocols, including:
– Responding to inspector inquiries accurately and concisely.
– Proper handling of documents and records.
– Adherence to confidentiality and data integrity principles.
– Record training attendance and maintain logs for audit purposes.

4.4.2 Role-Playing Exercises
– Practice common inspection scenarios to build employee confidence.
– Review appropriate responses to questions related to quality systems, manufacturing processes, and regulatory submissions.

4.5 During the Inspection
4.5.1 Opening Meeting
– Welcome the FDA inspector and hold an opening meeting to:
– Introduce the inspection team.
– Provide an overview of the facility and operations.
– Clarify the scope and objectives of the inspection.

4.5.2 Inspection Activities
– Escort the inspector to requested areas and provide requested documents promptly.
– Take detailed notes on inspector observations and questions.
– Ensure employees remain professional, courteous, and factual in their responses.

4.5.3 Sampling and Testing
– Facilitate any on-site sampling or testing requested by the FDA inspector.
– Retain duplicate samples for internal analysis if applicable.

4.6 Post-Inspection Activities
4.6.1 Closing Meeting
– Participate in the closing meeting to:
– Review preliminary findings or observations.
– Seek clarification on any issues or concerns raised by the inspector.
– Discuss timelines for addressing observations.

4.6.2 Addressing Inspection Findings
– Categorize findings as:
– Critical: Requires immediate corrective actions.
– Major: Requires action to address quality or compliance risks.
– Minor: Requires correction of administrative or procedural issues.
– Develop a Corrective and Preventive Action (CAPA) plan and document all actions taken.

4.6.3 Submitting Responses
– Submit a formal response to the FDA addressing inspection findings, including:
– Detailed corrective actions and timelines.
– Supporting documentation or evidence.
– Maintain submission records and confirmation receipts.

4.7 Continuous Monitoring and Improvement
4.7.1 Ongoing Compliance
– Conduct periodic internal audits to ensure sustained compliance.
– Update SOPs, training materials, and quality manuals based on lessons learned.

4.7.2 FDA Updates
– Monitor FDA updates and adjust practices as needed to align with regulatory changes.

5) Abbreviations

– FDA: Food and Drug Administration
– PAI: Pre-Approval Inspection
– QA: Quality Assurance
– DMR: Device Master Record
– DHR: Device History Record
– CAPA: Corrective and Preventive Actions
– SOP: Standard Operating Procedure

6) Documents

– Mock Inspection Logs
– Internal Audit Reports
– Training Records
– Device Master Records (DMRs)
– Validation and Verification Reports
– Corrective Action Plans
– Regulatory Submission Records

7) Reference

– FDA CFR Title 21, Part 820: Quality System Regulation
– FDA Guidance on Pre-Approval Inspections
– ISO 13485: Medical devices – Quality management systems
– FDA’s Inspection Guides for Medical Devices

8) SOP Version

– Version: 1.0
– Effective Date: DD/MM/YYYY
– Approved by: [Name/Title]

Annexure

Annexure 1: Mock Inspection Log Template

Date	Observation	Severity	Action Taken	Responsible Team
DD/MM/YYYY	Incomplete validation report	Major	Validation updated and reviewed	QA Team

Annexure 2: Employee Training Log Template

Date	Employee Name	Training Topic	Trainer	Remarks
DD/MM/YYYY	Jane Smith	FDA Inspection Protocols	John Doe	Completed